University of Oklahoma: Endometrial Neoplasms trials

The registry lists 11 Endometrial Neoplasms studies with University of Oklahoma as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 8No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial CancerNot yet recruitingNCT07737795Phase 2
• Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A MutationTerminatedNCT05523440Phase 2Results posted
• Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or EndometriumCompletedNCT03476798Phase 2Results posted
• Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial CancerCompletedNCT03189446Phase 2Results posted
• Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid CancerCompletedNCT00542490Phase 2Results posted
• Pilot Window of Opportunity Trial (POET)Active, not recruitingNCT06129604Phase 2
• Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck CancerWithdrawnNCT05850663Not applicable
• Bariatric Education for Women With Obesity and Endometrial CancerTerminatedNCT05396794
• Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerActive, not recruitingNCT03932409Phase 1
• Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial CancerWithdrawnNCT03836157Phase 2
• Phase II Study of Atezolizumab + Bevacizumab in Endometrial CancerActive, not recruitingNCT03526432Phase 2